It is possible that the exact time of effect of simepaglutide after dosing may vary, subject to the severity of the disease, drug tolerance and other factors. In general, simepaglutide reaches its maximum concentration 1-3 days after administration and reaches steady state after 4-5 weeks of once-weekly dosing. Simeglutide is a drug for the control of adult type 2 diabetes mellitus (people who have not been able to control their blood glucose by receiving sulfonylureas and/or biguanides on the basis of dietary control and exercise), and this drug also has cardiovascular protective effects. Common side effects of simethicone include nausea, diarrhea, vomiting, and other gastrointestinal disturbances. This medication should not be used in type 1 diabetes mellitus, diabetic ketoacidosis, medullary thyroid cancer in the presence of a personal or family history, type 2 multiple endocrine neoplasia syndrome, or in patients who are allergic to this medication. The use of Simeglutide must be supervised by a medical professional.